Cargando…
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis
BACKGROUND: COVID-19 may spread through various ways ranging from asymptomatic to severe forms, until respiratory failure, critical conditions and death occurs. There is a particular concern for patients affected by multiple sclerosis, especially for those under disease-modifying treatments. Some st...
Autores principales: | Schiavetti, Irene, Ponzano, Marta, Signori, Alessio, Bovis, Francesca, Carmisciano, Luca, Sormani, Maria Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570399/ https://www.ncbi.nlm.nih.gov/pubmed/35158467 http://dx.doi.org/10.1016/j.msard.2021.103358 |
Ejemplares similares
-
Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data
por: Bovis, Francesca, et al.
Publicado: (2019) -
Coronavirus disease 2019 in Latin American patients with multiple sclerosis
por: Fragoso, Yara D., et al.
Publicado: (2021) -
COVID-19 severity among patients with multiple sclerosis treated with cladribine: A systematic review and meta-analysis
por: Albanese, Angela, et al.
Publicado: (2022) -
Quantitative assessment of finger motor performance: Normative data
por: Signori, Alessio, et al.
Publicado: (2017) -
Retinal Hyperreflecting Foci Associate With Cortical Pathology in Multiple Sclerosis
por: Pengo, Marta, et al.
Publicado: (2022)